ストックスクリーナーアプリを入手
15.60
2.42%
-0.50
前日終値:
$16.10
開ける：
$15.74
24時間の取引高:
5,114
Relative Volume:
0.01
時価総額：
$957.93M
収益：
-
当期純損益:
$-129.61M
株価収益率:
-5.2225
EPS:
-2.9871
ネットキャッシュフロー:
$-116.59M
1週間 パフォーマンス:
+2.04%
1か月 パフォーマンス:
-33.50%
6か月 パフォーマンス:
-3.18%
1年 パフォーマンス:
+122.17%
1日の値動き範囲:
$15.72
$15.74
1週間の範囲:
$15.02
$16.60
52週間の値動き範囲:
$6.67
$28.00
Jade Biosciences Inc Stock (JBIO) Company Profile
Compare JBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
15.74 | 979.84M | 0 | -129.61M | -116.59M | -2.9871 |
VRTX
Vertex Pharmaceuticals Inc
|
449.10 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
610.01 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.79 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
283.64 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.00 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 開始されました | H.C. Wainwright | Buy |
| 2025-10-09 | 開始されました | BTIG Research | Buy |
| 2025-07-14 | 開始されました | Jefferies | Buy |
| 2025-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2025-05-07 | 開始されました | Wedbush | Outperform |
| 2025-05-05 | 開始されました | Stifel | Buy |
| 2025-05-02 | 開始されました | TD Cowen | Buy |
| 2024-06-18 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-06-18 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-06-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-06-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-17 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-03-25 | 再開されました | Jefferies | Buy |
| 2023-12-08 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-12-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-08-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-02-11 | 開始されました | BTIG Research | Buy |
| 2021-07-26 | 開始されました | Cowen | Outperform |
| 2021-07-26 | 開始されました | Evercore ISI | Outperform |
| 2021-07-26 | 開始されました | Jefferies | Buy |
| 2021-07-26 | 開始されました | Wedbush | Outperform |
すべてを表示
Jade Biosciences Inc (JBIO) 最新ニュース
UBS Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $45 - Moomoo
UBS Initiates Jade Biosciences at Buy With $45 Price Target - Moomoo
UBS initiates Jade Biosciences stock at Buy on IgAN drug potential - Investing.com Canada
[Form 4] Jade Biosciences, Inc. Insider Trading Activity - Stock Titan
Jade Biosciences (JBIO) director granted 34,843 stock options at $15.22 strike price - Stock Titan
Jade Biosciences (JBIO) awards director 34,843 stock options at $15.22 - Stock Titan
Jade Biosciences (JBIO) director Erin Lavelle receives 34,843-share option grant - Stock Titan
Director Kiselak receives 34,843-share Jade Biosciences (JBIO) stock option grant - Stock Titan
Jade Biosciences (NASDAQ: JBIO) holders back charter and bylaw changes - Stock Titan
Jade Biosciences (JBIO) 10K Form and Latest SEC Filings 2026 - MarketBeat
Jade Biosciences Company Profile & Introduction - Moomoo
Fairmount funds lock up 19.99% stake in Jade Biosciences (JBIO) - Stock Titan
Jade Biosciences' JADE101 delivers deep IgA cuts, clearing path for kidney trials - MSN
Jade Biosciences Completes Public Offering of 11.5 Million Shares, Raising $172.5 Million for Autoimmune Disease Therapies - Moomoo
Jade Biosciences closes $172.5m public offering - scanx.trade
Jade Biosciences prices $150M public offering of common stock at $15/share - MSN
Jade Biosciences closes $172.5 million stock offering - Investing.com UK
Jade Biosciences closes $172.5 million stock offering By Investing.com - Investing.com South Africa
Jade Biosciences plans public offering, pre-funded warrants - MSN
Jade Biosciences Closes Public Offering of Shares - marketscreener.com
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Press Release: Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - 富途牛牛
Number of shareholders of Jade Biosciences, Inc. – NASDAQ:JBIO - TradingView
Watkins Advises Jade Biosciences on Public Offering of Common Stock - Latham & Watkins LLP
Jade Biosciences Launches Major Underwritten Equity Offering - TipRanks
Jade Bios prices $150M follow-on offering, 10M shares at $15; nets ~$140.3M - TradingView
Jade Biosciences (NASDAQ: JBIO) prices $150M common stock sale - Stock Titan
Jade Biosciences (NASDAQ: JBIO) files prospectus for 10M-share $150M offering - Stock Titan
JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors - TipRanks
Wedbush Analyst Ratings On PRAX, IDYA, EWTX, JADE - RTTNews
Stock Market Today: S&P 500, Dow, Nasdaq Futures Fall As House Challenges Trump's Military Authority— Broadcom, CrowdStrike In Focus (UPDATED) - Benzinga
Why is Jade Biosciences stock sliding 9% today? By Investing.com - Investing.com India
Press Release: Jade Biosciences Announces Proposed Underwritten Public Offering - Moomoo
Jade Biosciences Prices $150 Million Public Offering - marketscreener.com
Stock Market Today: S&P 500 Futures Fall, Dow Gains As House Challenges Trump's Military Authority—Broadcom, CrowdStrike, Lululemon In Focus - Sahm
Jade Biosciences prices $150 million public offering at $15 By Investing.com - Investing.com Canada
Jade Biosciences stock falls on public offering announcement By Investing.com - Investing.com South Africa
Jade Biosciences: Jefferies, TD Cowen and UBS Are Joint Book-Running Managers for the Offering >JBIO - Moomoo
Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock - Moomoo
Jade Biosciences stock falls on public offering announcement - Investing.com
Jade Biosciences prices $150 million public offering at $15 - Investing.com
Jade Biosciences Plans Public Offering - Moomoo
Jade Biosciences Announces Pricing of Public Offering of Common Stock - The Manila Times
Jade Biosciences Prices Public Offering Of 10 Million Shares at $15 Per Share - TradingView
Biotech Jade Biosciences prices $150M stock sale to fund autoimmune trials - Stock Titan
Jade Biosciences announces proposed public offering By Investing.com - Investing.com India
Jade Biosciences announces proposed public offering - Investing.com
Jade Biosciences Inc (JBIO) 財務データ
収益
当期純利益
現金流量
EPS
1.70%
0.89%
大文字化:
|
ボリューム (24 時間):